[Etiology of endocrine arterial hypertensions: about a series of cases].
Arterial hypertensions (HTA) of endocrine origin are a rare cause of hypertension; HTA overall prevalence don't exceed 4% of hypertensive patients. Research interest in endocrine HTA is due to the severity of some life-threatening, potentially curable and reversible forms of HTA. The aim of our study was to determine the clinical, paraclinical, etiological and therapeutic profile of secondary HTA of endocrine origin in patients treated in endocrinology department at the University Hospital Mohamed VI in Marrakech. We conducted a prospective, descriptive study spanned 4 years, enrolling 45 patients with endocrine HTA. The average age was 44.89 years, with a clear predominance of women (sex ratio 0.49). Etiology of endocrine HTA was dominated by pheochromocytoma (17 cases), hypercorticism (11 cases) and acromegaly (8 cases). HTA were paroxysmal in 24.4%. HTA were immediately classified as grade 3 severe in 40% of cases. HTA were complicated by heart disease in 24% of cases and by renal disease in 20% of cases. Curative treatment cleared up HTA in 60% of cases (27 cases). The diagnosis of secondary endocrine HTA is sometimes difficult because of the lack of clinical specificity. It is not unusual for HTA to be the only manifestation of the disease. In our study we noted the paroxysmal and severe nature of HTA. The potentially curable nature of HTA in more than two thirds of cases, demostrates the importance of early diagnosis of each severe HTA resistant to treatment or in the presence of suggestive clinical, biological or radiological signs.
Service d'Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition, Laboratoire PCIM/FMPM, CHU Mohamed VI, Marrakech, Maroc.
Naima
N
Bouznad
Service d'Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition, Laboratoire PCIM/FMPM, CHU Mohamed VI, Marrakech, Maroc.
Ghizlane
G
El Mghari
Service d'Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition, Laboratoire PCIM/FMPM, CHU Mohamed VI, Marrakech, Maroc.
Nawal
N
El Ansari
D000172:Acromegaly / Q000150:complications; D000310:Adrenal Gland Neoplasms / Q000150:complications; D000308:Adrenocortical Hyperfunction / Q000150:complications; D000328:Adult; D004700:Endocrine System Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D008297:Male; D010673:Pheochromocytoma / Q000150:complications; D011446:Prospective Studies; D012720:Severity of Illness Index
Endocrine HTA; acromegaly; hypercorticism; pheochromocytoma; primary aldosteronism